Trials / Completed
CompletedNCT00292188
P4 (Pregabalin for Peripheral Posttraumatic Pain)
A 9 Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Study Of Pregabalin (BID) In Subject With Posttraumatic Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of pregabalin compared to placebo in the treatment of posttraumatic peripheral neuropathic pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | pregabalin |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2006-02-15
- Last updated
- 2021-02-09
- Results posted
- 2009-10-05
Locations
44 sites across 11 countries: Belgium, Canada, Denmark, Finland, Italy, Netherlands, Portugal, Romania, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00292188. Inclusion in this directory is not an endorsement.